Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients

BACKGROUND: Colorectal cancer (CRC) remains a serious health concern worldwide. Despite advances in diagnosis and treatment, about 15 to 30% of stage II CRC patients subjected to tumor resection with curative intent, develop disease relapse. Moreover, the therapeutic strategy adopted after surgery i...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Cancer
Auteurs principaux: Ribeirinho-Soares, Sara, Pádua, Diana, Amaral, Ana Luísa, Valentini, Elvia, Azevedo, Daniela, Marques, Cristiana, Barros, Rita, Macedo, Filipa, Mesquita, Patrícia, Almeida, Raquel
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2021
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8025574/
https://ncbi.nlm.nih.gov/pubmed/33823840
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-021-08070-6
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires